-Advertisement-
Dry Eye
A new era in dry eye therapy: the semifluorinated alkane-based cyclosporine A eye drop, VEVYE®
By Priyanka Agarwal, PhD Dry eye disease (DED) continues to be one of the most prevalent ocular surface disorders impacting millions of patients worldwide. While several therapeutic strategies—from artificial tears to anti-inflammatory agents—are currently available for DED therapy, effective management of this chronic disorder remains an ongoing challenge. DED is...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
06 Nov, 2024
Jai Parekh, MD, MBA, spoke with Ophthalmology 360 at the...
Quizzes
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved